Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HMB Supplementation on Post-operative Muscle Mass and Function in Female Athletes
NCT05869812Phase 2Recruiting
- Sponsor
- University of Kansas Medical Center
- Start
- May 2023
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in atrophy (2 arms), sponsored by University of Kansas Medical Center. Primary endpoints: Change in leg lean muscle mass at 36 weeks and Muscle Mass at 36 weeks. Started May 2023; status: recruiting.
02
Conditions
atrophy
Beyond the preview
Go deeper on NCT05869812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05869812.